This report analyses the factors affecting access to treatment regimens for drug-resistant tuberculosis (DR-TB), including new and repurposed drugs. Detailed pricing profiles of key DR-TB drugs are also provided.
Format:
Report
Publication Date:
2016
ID:
34006
- International Agencies
- Policy Makers
- TB
- Extensively Drug-Resistant TB (XDR TB)
- MDR TB
- TB Treatment
- Treatment- Medication Information
- Treatment- TB Disease